Lifeworks Advisors, LLC Biogen Inc. Transaction History

Lifeworks Advisors, LLC

$496 Million
Q3 2024

A detailed history of Lifeworks Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Lifeworks Advisors, LLC holds 4,775 shares of BIIB stock, worth $699,394. This represents 0.19% of its overall portfolio holdings.

Number of Shares

4,775

Previous 6,349 24.79%

Holding current value

$699,394

Previous $1.47 Million 37.12%

% of portfolio

0.19%

Previous 0.42%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$189.07 - $236.8 $297,596 - $372,723	-1,574 Reduced 24.79%	4,775 $925,000
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $1.94 Million - $2.41 Million	-10,188 Reduced 61.61%	6,349 $1.47 Million
Q1 2024 May 10, 2024	BUY	$212.02 - $267.71 $567,153 - $716,124	2,675 Added 19.3%	16,537 $3.57 Million
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $298,270 - $359,039	1,340 Added 10.7%	13,862 $3.59 Million
Q3 2023 Nov 01, 2023	BUY	$253.3 - $285.89 $659,846 - $744,743	2,605 Added 26.27%	12,522 $3.22 Million
Q2 2023 Aug 02, 2023	BUY	$275.25 - $318.06 $2.05 Million - $2.37 Million	7,456 Added 302.97%	9,917 $2.82 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $75,428 - $85,947	-294 Reduced 10.67%	2,461 $684,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $227,700 - $276,661	-902 Reduced 24.67%	2,755 $762,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $1.91 Million - $2.64 Million	-9,834 Reduced 72.89%	3,657 $1.04 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $235,550 - $280,113	1,256 Added 10.27%	13,491 $2.75 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $549,725 - $692,625	2,837 Added 30.19%	12,235 $2.58 Million
Q4 2021 Feb 15, 2022	BUY	$223.92 - $287.77 $2.1 Million - $2.7 Million	9,398 New	9,398 $2.26 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lifeworks Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lifeworks Advisors, LLC with notifications on news.

Account

Lifeworks Advisors, LLC Biogen Inc. Transaction History